Charles S. Hemenway

Loyola University Chicago — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.9kcitations58works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(22), Acute Myeloid Leukemia Research(14), Protein Degradation and Inhibitors(10), Signaling Pathways in Disease(10), RNA Interference and Gene Delivery(7)

Publications58 total

Abstract 1729 Mllt1, an epigenetic reader protein, is required to maintain B-lymphopoiesis
Journal of Biological Chemistry·2025Open Access
Title: MLLT1 Is Required to Maintain Normal B-Lineage Hematopoiesis and Mitochondrial Function
Blood·2023Open Access
An Atypical Presentation of Hodgkin Lymphoma Invading the Myocardium
Journal of Pediatric Hematology/Oncology·2023· 2 cited
Supplementary Figure 4 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 4 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 1 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 5 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 5 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 3 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Methods, Figure Legends 1-5 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 2 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 1 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Data from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Methods, Figure Legends 1-5 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Data from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 2 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Supplementary Figure 3 from Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
2023Open Access
Re‐examining a strong recommendation based on low‐quality evidence in acute chest syndrome
Pediatric Blood & Cancer·2023· 2 citedOpen Access
Re-examining a Strong Recommendation Based on Low-Quality Evidence in Acute Chest Syndrome
2022Open Access
Emergence of a Ph-negative Clone in a Child With Ph+ ALL
Journal of Pediatric Hematology/Oncology·2019· 2 cited
page 1 of 3Next →

Frequent Co-authors

Nancy J. Zeleznik‐Le(15), Ming-Jin Chang(14), Nicholas J. Achille(14), Mary Rose Reisenauer(13), Wenzheng Zhang(13), Chau-Wen Chou(12), Joseph Heitman(11), Hongyu Wu(8), María E. Cárdenas(5), Hongyu Wu(4), Aravinda Kuntimaddi(3), Alyson Lokken(3), John H. Bushweller(3), Andrea C de Erkenez(3), Grahame C.D. Gould(3), Jacqueline B. Nesbit(3), Benjamin W. Halligan(3), Bhavna Malik(3), Jeffrey Lin(3), Nisha N. Barretto(3)